China authorizes Livzon Pharma’s COVID-19 vaccine for emergency use
New protein-based vaccine to be used as booster jab, local media reports.
China has approved Livzon Pharmaceutical Group's COVID-19 vaccine for emergency use, local media reported on Saturday.
Livzon’s protein-based vaccine is the eighth domestically developed vaccine that will be used as a booster shot in the country where nearly 90% of the population have received their primary vaccinations, according to Caixin Global’s website.
Most Read News
-
Ukraine claims it destroyed border guard ship in
-
Strait of Hormuz will reopen only ‘when Iran's rights
-
Czech foreign minister says Prague will continue
-
China urges US, Iran to avoid return of war, backs
-
Brazilian president calls Trump's proposed Hormuz
-
Iran condemns UK designation of IRGC as 'terror group'
-
Pakistani premier Sharif condemns Houthi strikes on
-
Israel kills 8 Palestinians, including police chief, in








